Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON46604Recruiting
Randomised, double-blind trial of biperiden, sponsored by Centre for Human Drug Research. Primary endpoints: Treatment-emergent adverse events, Concomitant medication and 12 more. Started Sep 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON46604.